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about concepts and practices of the CHW in some countries of South America. That
information will be useful to design a questionnaire addressed to healthcare man-
agers in those countries. METHODS: Publications review about CHW. The search-
ing has been done through the data bases LILACS andMEDLINE since 1970 till now.
The used keywords were: Agente Comunitário de Saúde, Agente Comunitario de
Salud, Community Health Aides, Community Health Workers, Lay Health Worker.
The countries includedwere Bolivia, Brazil, Colombia, Ecuador, and Peru RESULTS:
There were founded out 254 articles, 63% are later than 2000 and 62% come from
Brazil. Besides that, there were an previous literature review and reports of na-
tional and international organizations. The publications raise different issues re-
lated to CHW: roles and activities (generalist and specialist), recruitment and se-
lection, training, supervision and support, relationships with the formal health
services, incentives. The CHW may improve the access and the coverage of the
basic public healthcare services. Unlike, Bolivia, Colombia, Ecuador and Peru,
where most of the participation is voluntary and supported by NGO, in Brazil the
CHW are members of the Nacional Health System through the Family Health
Program. CONCLUSIONS: Literature have reported that CHW carry out a variety of
health tasks, and that CHW deliver a wide range of interventions in such areas as
maternal and child health, primary health care, malaria, tuberculosis and HIV/
AIDS prevention and control.
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OBJECTIVES: To evaluate the current national trends in Vitamin D prescribing
among the elderly seeking care in office-based physician provider settings.
METHODS: Cross-sectional study was conducted using the National Ambulatory
Medical Care Survey (NAMCS) data from 2000 to 2009. All ambulatory office visits
made by the elderly aged 65 years of age were included in the study. Bivariate
associations between vitaminD and study variables such as patient demographics,
region, physician’s specialty, insurance status, and osteoporosis diagnosis were
evaluated using chi square tests. Logistic regression analyses were conducted to
determine the predictive factors associated with a vitamin D. All analyses were
performed with SAS statistical software, version 9.1, at an alpha of 0.05. RESULTS:
Of the 279,819 office-based physician visits made by the NAMCS participants from
2000 through 2009, there were 74,904(26.7%) visits that met the inclusion criteria.
This estimate represented 2.4 billion physician-office visits from the elderly in the
United States during the 10-year period. Of the included visits, 1,112 (1.91%) were
associated with a vitamin D. Race was a significant predictor in both the adjusted
and unadjusted models. Visits from other races were two times more likely to
include vitamin D when compared to white race (Adjusted OR  1.54; 95% CI 1.17-
2.03), while visits made by black patients were less likely to include vitamin D
therapy (Adjusted OR  0.43; 95% CI 0.38-0.50). The visits made by osteoporosis
patients were five times more likely to be associated with vitamin D therapy than
visitsmade by patients without the diagnosis (Adjusted OR5.23; 95% CI 4.04-6.77).
CONCLUSIONS: This study indicated that very few patients were prescribed vita-
min D. The overall prescribing patterns of vitamin D therapy, however, showed a
steady and continuous increase during past decade in the United States.
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OBJECTIVES: To determine prescribers’ perceptions of near-real time messaging
for potential drug-drug interactions (PDDIs) using a fax alert drug utilization review
intervention.METHODS: This was a 6-month prospective studywhere a pharmacy
benefitmanager (PBM) distributed evidence-based summaries of 18 different PDDIs
that included references and suggested management strategies. Fax alerts were
individualized letters sent to the prescriber of the 2nd drug of a PDDI for an indi-
vidual patient. A 16-item questionnaire to assess prescribers’ perceptions of the
intervention accompanied each individualized PDDI evidence-based summary.
Descriptive and multivariate logistical regression analyses were used to assess
questionnaire responses. RESULTS: A total of 8075 fax alerts were distributed and
977 returned questionnaires, yielding a 12.1% response rate. 848 (86.8%) responses
were completed by physicians and 71 (7.3%) completed by nurse practitioners. The
most common PDDI fax alerts sent were for warfarin-statin (3511, 43.5%) and war-
farin-thyroid (2111, 26.1%) interactions. 42.6% of respondents agreed or strongly
agreed that fax alerts were a good way to communicate with them. A total of 37.5%
of respondents, however, either agreed or strongly agreed that the fax alert was a
“waste of my time.” 59.1% of respondents either disagreed or strongly disagreed
that theywould prefer to receive a telephone call when interactions like this occur.
50.5% indicated their computer system provided drug interaction alerts. When
asked to evaluate the evidence-based information provided in the alert, carbam-
azepine-macrolide, ciprofloxacin-tizanidine, and statin-macrolide alerts were
rated more favorable than other PDDIs. Prescribers who had received alerts and
specialists were less likely to respond to the questionnaire (OR0.685, p0.0001
and OR0.851, p0.0205, respectively). CONCLUSIONS: PBMs detect and notify
prescribers of PDDIs during claims adjudication. This study found that some pre-
scribers valued fax alerts, especially for less well-known PDDIs. PDDI alert pro-
grams should carefully select PDDIs and other screening criteria to ensure prescrib-
ers respond to messaging.
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OBJECTIVES: In Ukraine currently there is no national reimbursement system for
pharmaceutical products andmajor part of pharmaceutical provision, even in hos-
pitals, is covered by out-of-pocket payments of patients. The aim of this study was
to define what factors have an impact on drugs prescription process by hospital
clinical specialists in Ukraine.METHODS: A brief questionnaire was distributed to
conventional sample of 299 doctors with different specializations (surgeons, anes-
thesiologists, pulmonologists) from four Ukrainian cities (Odessa, Kiev, Dniprope-
trovsk, Lviv). Doctors were proposed to rank on10 points’ scale effectiveness, price,
efficiency, and number of patients a month he/she is ready to prescribe an antibi-
otic drug. A dependence between ranking of effectiveness, price, and efficiency of
the drug and a number of patients the doctor was ready to prescribe it were ana-
lyzed in SPSS using correlation and linear regression analyses. RESULTS: The re-
sponders’ missing rate was equal to 1% due to convenient sample selection and
face-to-face questionnaire distribution. The difference in answers within doctors
of different specializations was not statistically significant. Price of the drug was
negatively associated with frequency of drug’s prescription for doctors of all spe-
cializations (Beta  -0.171; Sig0.004). There were no difference is ranking of effi-
ciency and effectiveness (Pearson correlation 0.684; Sig 0.000). CONCLUSIONS: As
we conclude from the analysis, practical doctors in Ukraine highly associate effi-
ciency with effectiveness of the medical products. Though, clinical effectiveness
has an impact on prescription practice, the price is a determinant.
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OBJECTIVES: To use the theory of planned behavior (TPB) to predict Texas phar-
macists’ intention to report serious adverse drug effects (ADEs) to the Food and
Drug Administration (FDA).METHODS: Data were collected from practicing Texas
pharmacists using a mail questionnaire. The study measured intention to report
serious ADEs, attitude (A), subjective norm (SN), perceived behavioral control (PBC)
and demographic and practice characteristics. Intention (3 items) was measured
using a 7-point unipolar scale ranging from extremely unlikely (1) to extremely
likely (7). Attitude (5 items), SN (3 items) and PBC (2 items) were measured on a
7-point bipolar scale ranging from -3 (e.g., strongly disagree) to 3 (e.g., strongly
agree). Themodelwas run usingmultiple regression analysis.RESULTS:Amajority
of the 377 respondents were male (52.9%) and Caucasian (70.2%). Overall, pharma-
cists intended to report ADEs (mean 15.87, SD 4.22; range: 3-21), had a favorable
attitude toward reporting (mean  4.62, SD  4.92; range: -12 to 15), had a favor-
able SN (mean 5.65, SD 2.99; range:-5 to9) and strong PBC (mean 3.54, SD
2.69; range: -6 to6). A ( 0.221, p 0.001), SN ( 0.438, p 0.001) and PBC (
0.028, p  0.05) together accounted for 34.0 percent of the variance in intention to
report serious ADEs to the FDA (F  63.60, d.f.  3, 370, p 0.001). CONCLUSIONS:
Pharmacists showed a strong positive intent to report serious ADEs to the FDA.
Attitude and SN were significant predictors of intent. Strategies to help pharma-
cists report more ADEs should focus on helping pharmacists see the value of re-
porting and altering their perception of social pressure towards reporting. The TPB
has utility in predicting ADE reporting behavior.
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OBJECTIVES:There are conflicting reports as towhether two FDA “black box”warn-
ings regarding risk of mortality related to use of antipsychotic medications to treat
patients aged 65 with dementia and a growing body of evidence of other serious
adverse effects has resulted in decreased use. This analysis explores trends and
patterns of “off-label” use of antipsychotics in the elderly.METHODS: Longitudinal
analysis of a large nationally representative administrative claims database (2005-
2010). The sample includes Medicare, Medicaid and commercially insured patients
aged 65 enrolled 11-12monthswith at least three ormore prescription fills for the
same antipsychotic drug. RESULTS:Themajority of antipsychotic prescribing is for
“off label” conditions. Of the elderly 65 treated with antipsychotics in 2010, 32.8%
had a diagnosis of dementia, 24.3% anxiety disorder, and 20.9% depression; 11.3%
and 10.8% were for approved conditions bipolar disorder and schizophrenia. In
contrast to recent studies reporting significant declines in use of antipsychotics to
treat symptoms of dementia, this analysis reveals high and increasing rates of
use—20.6% of patients with dementia were prescribed antipsychotics in 2010. This
represents an 83 percent increase from 2005 (first black box warning for atypical
antipsychotics issued), but a slight decline from the peak rate of 21.8% in 2008 (FDA
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